Sources: CBC
Pfizer and its German partner BioNTech begin a clinical trial to test the safety and immune response of their Omicron-specific COVID-19 vaccine for adults under the age of 55 years. 2022-01-25
Pfizer and BioNTech begin a clinical trial testing of their COVID-19 vaccine on healthy children between the ages of six months and 11 years, which is considered a crucial step towards vaccinating children. 2021-03-25
Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses. 2021-01-12
The World Health Organization lists the Pfizer-BioNTech vaccine for emergency use. 2020-12-31
Ireland officially begins a vaccination programme against COVID-19 using Pfizer-BioNTech's tozinameran vaccine, with a 79-year-old woman from Dublin becoming the first person to receive the vaccine. 2020-12-29
Oman officially begins a vaccination campaign against COVID-19 using the Pfizer-BioNTech vaccine. The country is the last Gulf Cooperation Council member state to begin vaccinations. Health Minister Ahmed Al-Saidi is one of the first citizens to receive a dose of the vaccine. 2020-12-27
Mexico begins vaccinations with the Pfizer-BioNTech vaccine. An intensive care unit nurse in Mexico City becomes the first person in the country to receive the vaccine. 2020-12-24
Swissmedic approves the authorization of the Pfizer-BioNTech vaccine for use in Switzerland. 2020-12-19
Officials from The Pentagon say that they will receive 44,000 doses of the Pfizer-BioNTech's Tozinameran vaccine. However, it will not be mandatory for soldiers to receive the vaccine. 2020-12-9
Prime Minister Justin Trudeau says that the country will receive 240,000 doses of Pfizer and BioNTech’s vaccine candidate by the end of the year. 2020-12-7